Session 342 Neoadjuvant therapy in BRAF Wildtype (Negative) Anaplastic Thyroid Cancer.

Neoadjuvant therapy in BRAF Wildtype (Negative) Anaplastic Thyroid Cancer. From the 28th Annual International Thyroid Cancer Survivors' Conference in Houston, Texas. Presented by Siddharth Sheth, DO MPH, Medical Oncologist